from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0532/PE_PGRS6

LFCtreatmentdescriptionclass of inhibitor

-0.884

Amikacinug/mL Amikacintranslation

-1.771

Cap5-10ug/mL Capreomycintranslation

-1.255

Rox10-50 ug/mL Roxithromycintranslation

-0.740

SM2-5 ug/mL Streptomycintranslation

-1.343

Tet5-10 ug/mL Tetracyclinetranslation

0.415

Rif0.2-5ug/mL Rifampicintranscription

-2.103

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.261

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.145

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.416

CPZ10-50 ug/mL Chlorpromazinerespiration

0.144

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.499

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.193

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.467

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.206

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.808

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.176

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.138

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.371

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.167

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.863

KCN5-20 ug/mL Potassium cyaniderespiration

0.134

NaN30.2-2 mM Sodium aziderespiration

-0.794

Nigericin50 uM Nigericinrespiration

-0.300

TRC10-150 ug/mL Triclosanrespiration

-0.121

TRZ10-25 ug/mL Thioridazinerespiration

-1.267

Valinomycin0.5-10 uM Valinomycinrespiration

-1.612

ZnSO42 mM ZnSO4respiration

-0.314

menadione6-10 ug/mL Menadionerespiration

0.394

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.367

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.705

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.623

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.658

NRP_1Non-replicating persistence stage 1dosRassociated

-0.527

Amp0.2mg/mL AmpicillincellWall

-0.022

Cephalexin20-100 ug/mL CephalexincellWall

-0.136

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.158

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.577

EMB10-20 ug/mL EthambutolcellWall

-0.497

Eta12-40 ug/mL EthionamidecellWall

0.234

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.470

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.325

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.123

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.159

BZA0.12 mg/mL BenzamidearomaticAmides

0.233

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.510

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.219

H2O24 mM hydrogen peroxideDNAdamaging

-0.417

Levo10 ug/mL LevofloxacinDNAdamaging

0.204

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.789

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.304

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.575

UVUV-irradiationDNAdamaging

0.751

ARP41-4 ug/mL Antitubercular compound ARP4?

0.470

Antimycin12.5-50 ug/mL Antimycin A?

-0.807

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.069

PA_110-50 ug/mL Antitubercular compound PA-1?

0.469

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.658

PA8240.2-2 ug/mL PA-824?

0.920

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.969

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.701

Verapamil50 uM Verapamil?

-0.683

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.094

methoxatin10-20 ug/mL Methoxatin?